Prostate Specific Antigen News and Research

RSS

Targeted screening effective in reducing prostate cancer deaths

A new study published in the journal PLOS Medicine shows that the number of prostate cancer deaths could be reduced by a sixth by simply introducing targeted screening, which is directed at detecting cases among men whose genes put them at higher risk of the disease.

22 Dec 2019

Target at-risk patients for prostate cancer screening, say experts

Almost one in six deaths from prostate cancer could be prevented if targeted screening was used for men at a higher genetic risk for the disease.

20 Dec 2019

Movember and Alberta Cancer Foundation campaigns boost prostate cancer screening study

Nanostics Inc. announced today that from the launch of its clinical validation study for ClarityDX Prostate, recruitment of men increased significantly in November, pushing the number of men enrolled over 200.

3 Dec 2019

MRI-guided ultrasound ablation: safer better treatment for prostate cancer

Prostate cancer may soon be treated more effectively using ultrasound at therapeutic levels, without the significant and distressing side effects of more traditional treatments. A new study presented on December 2, 2019, presents the outcome of using focused ultrasound ablation under MRI guidance in a novel procedure that can be used to treat both benign and malignant enlargement of the prostate gland.

2 Dec 2019

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more on immunotherapy, a major clinical trial has shown.

27 Nov 2019

Study explores the overall rate of new cancer cases in Canada from 1971 to 2015

The overall rate of new cancer cases is decreasing in men but increasing in women younger than 80 years, and obesity-related cancers are increasing in young people, according to a study on cancer trends in Canada from 1971 to 2015 published in CMAJ (Canadian Medical Association).

18 Nov 2019

Clinical benefit of anticoagulants for atrial fibrillation decreases with age, shows study

The net clinical benefit of anticoagulants for atrial fibrillation (AF) -- one of the most important causes of irregular heartbeats and a leading cause of stroke -- decreases with age, as the risk of death from other factors diminishes their benefit in older patients, according to a study led by researchers at UC San Francisco.

11 Nov 2019

Popular health campaigns aren’t always the most productive, says new study

Researchers have found that just because a public health campaign is popular among the digital community, it doesn’t mean it will produce gains in healthy behavior. This study, published in Lancet Oncology, concludes that in addition to attractive slogans or easy-to-understand captions and images, the relevance of the focused health issue to the target audience and to current guidelines may guide audience behavior.

31 Oct 2019

Internet popularity of health awareness campaigns may not always inspire action

A new study published in Lancet Oncology reveals that the internet popularity of health awareness campaigns may not always translate into a greater interest in related health behaviors.

31 Oct 2019

Multi-centre registry trial tests use of PSMA tracer for early detection of prostate cancer

Led by researchers at Lawson Health Research Institute, a multi-centre registry trial is testing the use of a new imaging tracer, called a PSMA tracer, for early detection of recurrent prostate cancer. The registry gives patients access to a new type of imaging and will assess the impact on patient care.

30 Oct 2019

Unique biomarker in urine may offer non-invasive means of detecting prostate cancer

A research study published in the journal Neoplasia and led by principal investigator Nallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute at Henry Ford Health System, has identified a novel prostate cancer gene fusion involving the KLK4 protein coding gene and KLKP1 pseudogene.

3 Oct 2019

Long-term hormone therapy does more harm than good for men with low PSAs after prostate surgery

A secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer finds long-term hormone therapy does more harm than good for many men and calls for rethinking treatment guidelines based on a patient's post-operative prostate-specific antigen (PSA) level.

26 Sep 2019

Pre-SRT PSA could serve as prognostic and predictive biomarker of benefit from hormone therapy

Initial results of NRG Oncology Clinical Trial RTOG 9601 in men with biochemically recurrent prostate cancer receiving salvage radiotherapy demonstrated improvement in OS from the addition of long-term hormone therapy to SRT.

17 Sep 2019

PSA testing can help detect prostate cancer in men with BRCA2 gene fault

Men with the BRCA2 gene fault have an increased risk of prostate cancer and could benefit from PSA (prostate specific antigen) testing to help detect the disease earlier, according to researchers funded by Cancer Research UK.

17 Sep 2019

Researchers are working to develop new biosensor for detecting recurrence of prostate cancer

A team of researchers from the University of Houston and the University of Pennsylvania are working to bring a new biosensor for detecting the recurrence of prostate cancer to the doctor's office.

12 Sep 2019

Non-invasive accurate blood test for prostate cancer

For men, one of the most dreaded moments could be hearing, “We’re not yet sure, but your PSA is high; you’ll have to come for further tests.” This could start a chain of events which ends in the diagnosis of prostate cancer - including a prostate biopsy, and ending in a major surgery for prostate removal.

11 Sep 2019

Prostate Specific Antigen News and Research

Targeted screening effective in reducing prostate cancer deaths

Target at-risk patients for prostate cancer screening, say experts

Movember and Alberta Cancer Foundation campaigns boost prostate cancer screening study

MRI-guided ultrasound ablation: safer better treatment for prostate cancer

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Study explores the overall rate of new cancer cases in Canada from 1971 to 2015

Clinical benefit of anticoagulants for atrial fibrillation decreases with age, shows study

Popular health campaigns aren’t always the most productive, says new study

Internet popularity of health awareness campaigns may not always inspire action

Multi-centre registry trial tests use of PSMA tracer for early detection of prostate cancer

Unique biomarker in urine may offer non-invasive means of detecting prostate cancer

Long-term hormone therapy does more harm than good for men with low PSAs after prostate surgery

Pre-SRT PSA could serve as prognostic and predictive biomarker of benefit from hormone therapy

PSA testing can help detect prostate cancer in men with BRCA2 gene fault

Researchers are working to develop new biosensor for detecting recurrence of prostate cancer

Non-invasive accurate blood test for prostate cancer

Simple blood test found to efficiently, accurately detect aggressive prostate cancer

New blood test can detect clinically significant prostate cancer in high-risk patients

Adjuvant radiotherapy may help treat locally advanced prostate cancer

Perspectives on how to communicate to older adults about stopping cancer screening

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News